ApoB100-reactive T cells: Does liver tolerance hold the key to modulating adaptive immunity in atherosclerosis?

Daniel F.J. Ketelhuth

doi:10.1111/joim.13436

ApoB100-reactive T cells: Does liver tolerance hold the key to modulating adaptive immunity in atherosclerosis?

Daniel F.J. Ketelhuth^*

^*Kontaktforfatter

Kardiovaskulær & Renalforskning

Karolinska Institutet

Publikation: Bidrag til tidsskrift › Leder › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Internal Medicine
Vol/bind	291
Udgave nummer	5
Sider (fra-til)	530-532
ISSN	0954-6820
DOI	https://doi.org/10.1111/joim.13436
Status	Udgivet - maj 2022

Bibliografisk note

Funding Information:
Daniel F.J. Ketelhuth is supported by grants from the Novo Nordisk Foundation (MSAM consortium, NNF15SA0018346; MeRIAD consortium, 0064142), and the University of Southern Denmark.

Finansiering

Daniel F.J. Ketelhuth is supported by grants from the Novo Nordisk Foundation (MSAM consortium, NNF15SA0018346; MeRIAD consortium, 0064142), and the University of Southern Denmark.

Dokumenter og links

10.1111/joim.13436Licens: Ikke-specificeret

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{7dc710f96b8842bb8354d7a98ddd517c,

title = "ApoB100-reactive T cells: Does liver tolerance hold the key to modulating adaptive immunity in atherosclerosis?",

keywords = "Adaptive Immunity, Apolipoprotein B-100, Atherosclerosis, Humans, Liver, T-Lymphocytes",

author = "Ketelhuth, \{Daniel F.J.\}",

note = "Funding Information: Daniel F.J. Ketelhuth is supported by grants from the Novo Nordisk Foundation (MSAM consortium, NNF15SA0018346; MeRIAD consortium, 0064142), and the University of Southern Denmark. ",

year = "2022",

month = may,

doi = "10.1111/joim.13436",

language = "English",

volume = "291",

pages = "530--532",

journal = "Journal of Internal Medicine",

issn = "0954-6820",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - ApoB100-reactive T cells

T2 - Does liver tolerance hold the key to modulating adaptive immunity in atherosclerosis?

AU - Ketelhuth, Daniel F.J.

N1 - Funding Information: Daniel F.J. Ketelhuth is supported by grants from the Novo Nordisk Foundation (MSAM consortium, NNF15SA0018346; MeRIAD consortium, 0064142), and the University of Southern Denmark.

PY - 2022/5

Y1 - 2022/5

KW - Adaptive Immunity

KW - Apolipoprotein B-100

KW - Atherosclerosis

KW - Humans

KW - Liver

KW - T-Lymphocytes

U2 - 10.1111/joim.13436

DO - 10.1111/joim.13436

M3 - Editorial

C2 - 35028996

AN - SCOPUS:85122819300

SN - 0954-6820

VL - 291

SP - 530

EP - 532

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

IS - 5

ER -